94,32 €
1,86 % heute
L&S, 15. Juli, 21:30 Uhr
ISIN
US3755581036
Symbol
GILD
Berichte
Sektor
Industrie

Gilead Sciences Aktie News

Neutral
Investors Business Daily
18 Tage alt
The U.S. Supreme Court could make a decision Friday that would rattle Gilead Sciences' newest HIV prevention drug.
Neutral
Investors Business Daily
19 Tage alt
President Donald Trump, ever the negotiator, is angling to lower drug prices through his Most Favored Nation policy. But will it work?
Positiv
Proactive Investors
20 Tage alt
Gilead Sciences Inc (NASDAQ:GILD, ETR:GIS) and Kymera Therapeutics (NASDAQ:KYMR) have entered into an exclusive option and license agreement focused on developing a novel cancer treatment targeting cyclin-dependent kinase 2 (CDK2), a protein that plays a key role in tumor growth. This collaboration aims to accelerate the development and commercialization of a new class of drugs called molecular...
Positiv
Reuters
20 Tage alt
Gilead Sciences has entered into an option and license deal with Kymera Therapeutics to support the development and sales of a class of cancer drugs, the companies said on Wednesday.
Neutral
Business Wire
20 Tage alt
FOSTER CITY, Calif. & WATERTOWN, Mass.--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ: GILD) and Kymera Therapeutics, Inc. (NASDAQ: KYMR), today announced that they have entered into an exclusive option and license agreement to accelerate the development and commercialization of a novel molecular glue degrader (MGD) program targeting cyclin-dependent kinase 2 (CDK2) with broad oncology treatme...
Positiv
Seeking Alpha
21 Tage alt
Buying Dividend Aristocrats at bargain prices can be a winning investment strategy. I highlight two such names that are undervalued compared to historical norms while paying strong and well-covered dividends. Both carry moat-worthy attributes and provide economically essential products and services that make them recession resilient.
Positiv
24/7 Wall Street
24 Tage alt
Investors love growth stocks that also pay big and reliable dividends because they provide dependable passive income streams and an excellent opportunity for solid total return.
Negativ
Investors Business Daily
25 Tage alt
The latest shake-up at the FDA forced out the top two officials in charge of reviewing cell and gene therapies, analysts said.

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen